GlassScriptPrepare for your visit
Namit Mahajan
Vascular & Interventional Radiology · Richmond, VA · NPI 1043476815
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$30,140.44
in general payments reported to CMS, 2019-2025 · $13K in 2025
The $13K reported for 2025 was more than what 91% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Who reported paying
General payments only, top 6 by amount.
- Penumbra, INC. $11,268.16
- Angiodynamics, INC. $6,541.36
- Astrazeneca Pharmaceuticals LP $4,500.00
- Inari Medical, INC. $1,184.20
- Medtronic USA, INC. $1,081.73
- Boston Scientific Corporation $999.68
Drugs and devices associated with these payments
Indigo System Auryon Laser System 100-120 Vac Azur Cx Detachable Penumbra System Trinav Infusion System Flowtriever Catheter, S Ct Thrombectomy System Kit Sir-Spheres Microspheres Lava Les (Liquid Embolic System) Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial) Zoom 88-T Large Distal Platform Alphavac
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Namit Mahajan listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/320060/namit-mahajan